Thomas Andrew Davis

Companies

• Genocea (United States)CHIEF MEDICAL OFFICER Oct 1, 2018 to Apr 5, 2022¹
• Celldex TherapeuticsSen. VP & Ch. Medical Officer Mar 25, 2008 to Jun 16, 2017²
• GenVecChief Medical Officer Jan 5, 2006 to Jan 26, 2006³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GUGenocea (United States)68,330 shares⁴Apr 4, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 4, 2022Sold 1,091 shares at $1.25 of Genocea (United States)⁴
• Mar 16, 2022Sold 2,717 shares at $1.10 of Genocea (United States)⁵
• Mar 15, 2022Granted 31,250 shares of Genocea (United States)⁵
• Jun 1, 2021Sold 524 shares at $2.23 of Genocea (United States)⁶
• Apr 2, 2021Sold 948 shares at $2.71 of Genocea (United States)⁶